Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)

NCT06903156 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open-Angle Glaucoma (POAG)

Interventions

DRUG: Mexidol
OTHER: Placebo

Sponsor

Pharmasoft